MarketPulse

FDA-cleared

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

NeurAxis to Report Q1 2026 Results as Neuromodulation Startup Eyes Commercial Traction

NeurAxis will report Q1 2026 financial results on May 12, 2026, as the neuromodulation company continues commercializing its FDA-cleared IB-Stim technology.
NRXSmedical technologyQ1 2026 earnings
BenzingaBenzinga··Na

Merit Medical Expands Oncology Push with $140M View Point Medical Acquisition

Merit Medical Systems acquires View Point Medical for $140M, adding breast cancer imaging technology. Expected to dilute 2026 earnings but turn accretive in 2027.
MMSIacquisitionbreast cancer
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

T. Rowe Price CEO Joins Longeviti Board as Neurotech Firm Scales AI Brain Health Platform

T. Rowe Price CEO Robert W. Sharps joins Longeviti Neuro Solutions' board, bringing three decades of asset management expertise to support the AI-driven neurotechnology company's growth.
TROWartificial intelligencecorporate governance